Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytoplasmic endogenous regulator of oxidative phosphorylation 1 (CEROX1) is an unusually abundant, cytoplasmic long non-coding RNA conserved across placental mammals, characterized as the first lncRNA demonstrated to post-transcriptionally regulate mitochondrial oxidative phosphorylation. Through competitive binding with microRNAs (notably miR-488-3p), CEROX1 modulates the abundance and enzymatic activity of mitochondrial complex I and IV subunits, thereby influencing cellular energy metabolism, reducing oxidative stress, and protecting cells against the toxicity of inhibitors like rotenone. Changes in CEROX1 levels have profound effects on mitochondrial function, with implications for diseases associated with mitochondrial dysfunction and oxidative damage.
Post-transcriptional decoying of microRNAs (especially miR-488-3p), resulting in upregulation of complex I subunit transcripts. Increasing the abundance and activity of complex I and IV by modulating transcript and protein levels through miRNA competition.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytoplasmic endogenous regulator of oxidative phosphorylation 1 (CEROX1).